go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Biegler GmbH

Organization type
RDM medtech
Region
Lower Austria
Details

Heltschl GmbH

Organization type
RDM medtech
Region
Upper Austria
Details

Greiner Bio-One GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
single-use devices
Details

CMD GmbH

Organization type
RDM medtech
Region
Upper Austria
Topic
Other
Details

Contact



Contact: